Learn more

SB PHARMCO INC

Overview
  • Total Patents
    235
About

SB PHARMCO INC has a total of 235 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United Kingdom, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are FOVEA PHARMACEUTICALS SA, KRONOS BIO INC and BIOPROJET PHARMA.

Patent filings per year

Chart showing SB PHARMCO INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Re Vincenzo 32
#2 St-Denis Yves 20
#3 Andreotti Daniele 18
#4 Tellew John Edward 17
#5 Heafield Joanne 17
#6 Saunders Ann M 16
#7 Katrincic Lee M 16
#8 Luo Zhiyong 15
#9 Sale Mark Edward 15
#10 Oh Choon K 15

Latest patents

Publication Filing date Title
KR20080056731A Combination of rosiglitazone and donepezil for improvement of cognitive function
CN101312728A Pharmaceutical composition for improvement of cognitive function
MX2007004701A Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists.
CN101084219A Pyrazolo(1,5-alpha)pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists
GB0519957D0 Chemical compound
GB0507195D0 Process for preparing bicyclic compounds
GB0507207D0 Process for preparing bicyclic compounds
GB0507202D0 Process for preparing bicyclic compounds
GB0507198D0 Process for preparing bicyclic compounds
GB0502477D0 Novel compositions
GB0502475D0 Novel compositions
GB0502478D0 Novel compositions
GB0502479D0 Novel compositions
WO2005063756A1 Crf receptor antagonists and methods relating thereto
EP1697362A1 Crf receptor antagonists and methods relating thereto
CA2547137A1 Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
WO2005051383A1 Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
TW200517127A Novel composition
CN101434604A Condensed n-heterocyclic compounds and their use as CRF receptor antagonists
GB0407724D0 Process for preparing bicyclic compounds